ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Journal of the Neurological Sciences
Volume 108, Issue 2, April 1992, Pages 178-183
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Purchase PDF (528 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/0022-510X(92)90048-P    How to Cite or Link Using DOI (Opens New Window)
Copyright © 1992 Published by Elsevier Science B.V.

Characterization of a transthyretin-related amyloid fibril protein from cerebral amyloid angiopathy in type I familial amyloid polyneuropathy

Fuyuki Kametani1, Shu-ichi Ikeda2, Corresponding Author Contact Information, Nobuo Yanagisawa2, Tsuyoshi Ishi3 and Norinao Hanyu4

1 Department of Molecular Biology, Psychiatric Research Institute of Tokyo, Tokyo 156, Japan 2 Department of Medicine (Neurology), Shinshu University School of Medicine, Matsumoto 390, Japan 3 Department of Ultrastructure, Psychiatric Research Institute of Tokyo, Tokyo 156, Japan 4 Department of Neurology, Nagao Red Cross Hospital, Nagano 380, Japan

Received 28 June 1991; 
revised 14 October 1991; 
accepted 14 October 1991. ;
Available online 14 March 2003.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Recently, it has been reported that transthyretin (TTR)-immunoreactive amyloid deposition with cerebral amyloid angiopathy in central nervous system is a common pathological finding in type I familial amyloid polyneuropathy (FAP). In the present study, we performed isolation and sequence analysis of TTR-related amyloid fibril protein from the meninges of a patient with type I FAP. Purified major amyloid fibril protein had a molecular weight of 15 kDa. Complete sequence analysis revealed that this amyloid fibril protein was a variant TTR with a single amino acid substitution of methionine for valine at position 30. This variant TTR is a previously unrecognized as cerebrovascular amyloid fibril protein. Furthermore, the patients with type I FAP are well known to have the variant TTR in the serum. These suggest that cerebrovascular amyloid fibril protein in type I FAP may derive from a serum precursor.

Author Keywords: Familial amyloid polyneuropathy; Cerebral amyloid angiopathy; Amyloid; Transthyretin; Amyloid fibril protein; Amino acid sequence

Article Outline

• References

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.